We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$88.5B
AUM Growth
+$2.22B
Cap. Flow
-$721M
Cap. Flow %
-0.82%
Top 10 Hldgs %
14.33%
Holding
2,695
New
65
Increased
1,198
Reduced
577
Closed
89

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$205M
2
JNJ icon
Johnson & Johnson
JNJ
+$186M
3
HON icon
Honeywell
HON
+$177M
4
MDLZ icon
Mondelez International
MDLZ
+$132M
5
BABA icon
Alibaba
BABA
+$130M

Sector Composition

Rank Sector Weight
1 Healthcare 15.89%
2 Technology 14.47%
3 Financials 12.9%
4 Consumer Discretionary 10.06%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THFF icon
2201
First Financial Corp
THFF
$985M
$276K ﹤0.01%
7,526
IQNT
2202
DELISTED
Inteliquent, Inc.
IQNT
$276K ﹤0.01%
13,900
HRTX icon
2203
Heron Therapeutics
HRTX
$96.8M
$274K ﹤0.01%
15,200
LGIH icon
2204
LGI Homes
LGIH
$1.43B
$274K ﹤0.01%
8,581
EVH icon
2205
Evolent Health
EVH
$350M
$273K ﹤0.01%
14,200
-19,845
-58% -$273K
TBPH icon
2206
Theravance Biopharma
TBPH
$875M
$273K ﹤0.01%
+12,019
New +$260K
RAVN
2207
DELISTED
Raven Industries Inc
RAVN
$273K ﹤0.01%
14,399
SSNI
2208
DELISTED
Silver Spring Networks, Inc.
SSNI
$273K ﹤0.01%
22,500
UTEK
2209
DELISTED
Ultratech Inc.
UTEK
$273K ﹤0.01%
11,899
SGRY icon
2210
Surgery Partners
SGRY
$2.05B
$272K ﹤0.01%
+15,200
New +$226K
BH icon
2211
Biglari Holdings Class B
BH
$1.23B
$271K ﹤0.01%
1,008
INGN icon
2212
Inogen
INGN
$187M
$271K ﹤0.01%
5,400
PRIM icon
2213
Primoris Services
PRIM
$4.93B
$271K ﹤0.01%
14,299
ANH
2214
DELISTED
Anworth Mortgage Asset Corporation
ANH
$271K ﹤0.01%
57,628
MG icon
2215
Mistras Group
MG
$507M
$270K ﹤0.01%
11,299
ORBC
2216
DELISTED
ORBCOMM, Inc.
ORBC
$268K ﹤0.01%
26,900
FFG
2217
DELISTED
FBL Financial Group
FFG
$267K ﹤0.01%
4,401
HTLF
2218
DELISTED
Heartland Financial USA, Inc.
HTLF
$266K ﹤0.01%
+7,548
New +$252K
LSAK icon
2219
Lesaka Technologies
LSAK
$415M
$265K ﹤0.01%
26,490
+900
+4% +$9.57K
TOWR
2220
DELISTED
Tower International, Inc.
TOWR
$265K ﹤0.01%
12,900
SHOR
2221
DELISTED
ShoreTel, Inc.
SHOR
$265K ﹤0.01%
39,600
ANGO icon
2222
AngioDynamics
ANGO
$628M
$264K ﹤0.01%
18,398
SPXC icon
2223
SPX Corp
SPXC
$10.8B
$264K ﹤0.01%
17,783
NXGN
2224
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$264K ﹤0.01%
22,198
CWEN.A
2225
DELISTED
Clearway Energy Class A
CWEN.A
$263K ﹤0.01%
17,300

Similar funds

UBS AM's Q2 2016 Portfolio in Review

As of Q2 2016, UBS AM held 2,695 positions worth $88.5B, up 2.6% from $86.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2016 filing shows 65 new, 1,198 increased, 577 reduced and 89 closed positions. Its largest new stake was S&P Global: 1,914,020 shares worth $205M. The largest sale was MCGRAW-HILL FINANCIAL INC COM, an estimated $270M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2016 buy was S&P Global: 1,914,020 shares worth $205M.
  • UBS AM added most to Johnson & Johnson in Q2 2016, an estimated $186M increase.
  • UBS AM's biggest Q2 2016 reduction was Citigroup, cutting an estimated $185M.
  • UBS AM fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $270M.
  • UBS AM's ten largest holdings make up 14% of its $88.5B portfolio in Q2 2016.
  • UBS AM opened 65 new positions and closed 89 in Q2 2016.
  • UBS AM's portfolio value rose 2.6% quarter-over-quarter to $88.5B.

Based on UBS AM's 13F filing for Q2 2016, filed 9 Aug 2016.